Impact of Culprit Plaque and Atherothrombotic Components on Incomplete Stent Apposition in Patients With ST-Elevation Myocardial Infarction Treated With Everolimus-Eluting Stents　- An OCTAVIA Substudy.

BACKGROUND The role of culprit plaque and related atherothrombotic components on incomplete stent apposition (ISA) occurrence after primary percutaneous coronary intervention (p-PCI) is unknown. METHODSANDRESULTS ST-segment elevation myocardial infarction (STEMI) patients undergoing p-PCI with an everolimus-eluting stent were prospectively investigated with optical coherence tomography (OCT) of the infarct-related artery before, after stenting and at 9 months. OCT data, aspirated thrombus and serum inflammatory biomarkers were analyzed. 114 patients with 114 lesions were evaluated. Acute ISA occurred in 82 lesions (71.9%), preferentially in larger vessels with a median area of 0.2 mm(2). The presence of thrombus before stent implantation (odds ratio (OR) 5.5, 95% confidence interval (CI) [1.1-26.9], P=0.04) and the lipid content in the target segment (OR 1.3, 95% CI [1.0-1.5], P=0.04) independently predicted acute ISA. At 9-month follow-up, ISA persisted in 46 lesions (56.1%). The volume of acute ISA significantly predicted persistent ISA (OR 1.3, 95% CI [1.1-1.5], P=0.01). Late-acquired ISA occurred in 39 lesions (34.2%) with a median area of 0.3 mm(2). Red/mixed thrombus before stent implantation (OR 3.7, 95% CI [1.0-13.3], P=0.05) and length of the underlying ruptured plaque (OR 1.7, 95% CI [1.1-2.8] P=0.02) were independently associated with late-acquired ISA. CONCLUSIONS In STEMI patients, culprit plaque and atherothrombotic components of the infarct-related artery significantly contribute to the onset of acute and late ISA. ISA persistence at follow-up depends on the initial volume of acute ISA.

[1]  T. Akasaka,et al.  Feasibility of optical coronary tomography in quantitative measurement of coronary arteries with lipid-rich plaque. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[2]  S. Umemura,et al.  Clinical utility and significance of intravascular ultrasound and optical coherence tomography in guiding percutaneous coronary interventions. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[3]  R. Virmani,et al.  Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. , 2014, JACC. Cardiovascular interventions.

[4]  Yohei Ohno,et al.  Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition. , 2014, Journal of the American College of Cardiology.

[5]  Eloisa Arbustini,et al.  Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. , 2014, Coronary artery disease.

[6]  Y. Jang,et al.  Incidences, Predictors, and Clinical Outcomes of Acute and Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent Implantation , 2014, Circulation. Cardiovascular interventions.

[7]  G. Mintz,et al.  Comparison of Manual Thrombus Aspiration With Rheolytic Thrombectomy in Acute Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.

[8]  P. Serruys,et al.  Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. , 2013, European heart journal.

[9]  H. Garcia-Garcia,et al.  Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction. , 2012, JACC: Cardiovascular Interventions.

[10]  P. Serruys,et al.  Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study. , 2012, JACC. Cardiovascular interventions.

[11]  Akiko Maehara,et al.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.

[12]  P. Serruys,et al.  Vascular Tissue Reaction to Acute Malapposition in Human Coronary Arteries: Sequential Assessment With Optical Coherence Tomography , 2012, Circulation. Cardiovascular interventions.

[13]  F. Eberli,et al.  Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. , 2012, European heart journal.

[14]  Gary S. Mintz,et al.  Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial , 2011, Circulation.

[15]  G. Stone,et al.  Incidence, Mechanisms, Predictors, and Clinical Impact of Acute and Late Stent Malapposition After Primary Intervention in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HOR , 2010, Circulation.

[16]  P. Serruys,et al.  An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. , 2010, European heart journal.

[17]  Pierfrancesco Agostoni,et al.  Quantitative coronary angiography in the current era: principles and applications. , 2009, Journal of interventional cardiology.

[18]  Peter Jüni,et al.  Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis , 2009, Circulation.

[19]  Patrick W Serruys,et al.  Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherenc , 2009, JACC. Cardiovascular interventions.

[20]  R. Costa,et al.  Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. , 2008, Journal of interventional cardiology.

[21]  Takashi Akasaka,et al.  Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. , 2008, JACC. Cardiovascular imaging.

[22]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.